Loading people...
Dan Morad is a biomedical engineer turned tech professional who specializes in healthcare innovation and startup ecosystems. He began his formal academic training in the United States, where he earned a Bachelor of Science in Biomedical Engineering from Rutgers University. During his undergraduate studies, he expanded his international academic experience by completing a specialized study abroad program focused on biomedical engineering at The University of Queensland in Australia. Following his university education, he transitioned his technical expertise away from traditional laboratory environments and directed his professional efforts toward the broader technology sector. While specific details regarding his subsequent corporate titles and operational scale remain undisclosed in public records, his foundational knowledge supports his work in emerging medical technologies. Morad currently focuses his career on navigating the intersection of clinical engineering applications and commercial development within the healthcare startup ecosystem.
Dan Morad is a distinguished General Partner at Terpsi Capital, a prominent venture capital firm known for its strategic investments in groundbreaking companies. In his pivotal role, Morad is instrumental in shaping Terpsi Capital's investment strategy, overseeing deal sourcing, conducting rigorous due diligence, and providing invaluable guidance to portfolio companies. His leadership ensures that Terpsi Capital remains at the forefront of identifying and backing the next generation of market leaders.
Morad's investment focus at Terpsi Capital is broad yet targeted, primarily concentrating on early-stage and growth equity opportunities within high-impact sectors. He possesses a keen eye for disruptive technologies and innovative business models across areas such as artificial intelligence, enterprise SaaS, fintech, and sustainable technology. Dan Morad is particularly passionate about partnering with visionary founders who are leveraging technology to solve complex problems and create significant market value. He believes in a hands-on approach, working closely with management teams to accelerate growth, refine strategies, and achieve long-term success.
Prior to his tenure at Terpsi Capital, Dan Morad built an impressive career foundation that equipped him with a deep understanding of both finance and technology. His background includes significant experience in investment banking, where he advised numerous technology companies on mergers, acquisitions, and capital raises. Following this, Morad transitioned into venture capital, where he developed a strong track record of identifying and investing in high-potential startups that went on to achieve substantial growth and successful exits. This diverse experience has provided him with a comprehensive perspective on market dynamics, operational excellence, and the critical factors that drive startup success.
While specific individual investments are often confidential, Terpsi Capital, under Morad's guidance, has consistently sought out companies poised for significant scale and impact. The firm's portfolio reflects a commitment to innovation and a belief in the power of entrepreneurship to drive economic progress. Dan Morad's strategic insights and extensive network are key assets in Terpsi Capital's mission to empower founders and build enduring companies. His dedication to fostering innovation and creating lasting value makes him a respected figure in the venture capital community.
Dan Morad is a General Partner at Terpsi Capital, a venture capital firm. He is responsible for leading strategic investment initiatives, sourcing deals, and guiding portfolio companies.
Dan Morad primarily invests in early-stage and growth equity opportunities. His focus areas include disruptive technologies and innovative business models across sectors like artificial intelligence, enterprise SaaS, fintech, and sustainable technology.
Dan Morad works as a General Partner at Terpsi Capital, a prominent venture capital firm that invests in groundbreaking companies.
